NCT00454207View on ClinicalTrials.gov

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Pulmonary Hypertension
Interventions
DRUG

sildenafil citrate (UK-92,480)

sildenafil citrate (UK-92,480)

Trial Locations (8)

Unknown

Pfizer Investigational Site, Chiba

Pfizer Investigational Site, Kanazawa

Pfizer Investigational Site, Tsu

Pfizer Investigational Site, Okayama

Pfizer Investigational Site, Hamamatsu

Pfizer Investigational Site, Bunkyo-ku

Pfizer Investigational Site, Shinjuku-ku

Pfizer Investigational Site, Tokyo

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00454207 - Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter